Trending News
Welcome to our list of the most viewed stock market news.
Updated every minute, this automated list is generated based on real-time analytics to bring you the news articles that are receiving the most attention right now.
Whether you're an investor, a trader, or simply curious about the financial markets, you'll find this list to be a valuable resource for keeping tabs on market trends and company updates.
Navigate through the top news and stay informed with the most current insights in the stock market world.
BigBear.ai (NYSE: BBAI), an AI technology provider specializing in defense, national security, travel, trade, and enterprise solutions, has announced its upcoming first quarter 2025 financial results release. The company will publish its earnings report on Thursday, May 1, 2025 at approximately 4:15 pm ET, followed by an earnings conference call later that evening. Investors can access the earnings release through the company's investor relations website at https://ir.bigbear.ai. Additional details regarding the earnings call will be made available on the same website on May 1, 2025.
- None.
- None.
Regeneron Pharmaceuticals (NASDAQ: REGN) has received a Complete Response Letter (CRL) from the FDA regarding their supplemental Biologics License Application for EYLEA HD® (aflibercept) Injection 8 mg. The application sought to extend dosing intervals up to 24 weeks across all approved indications.
The FDA did not identify any safety or efficacy concerns with EYLEA HD's currently approved indications and dosing regimens but rejected the proposal for additional extended dosing intervals beyond the current maximum of 16 weeks. EYLEA HD maintains its existing approval for dosing intervals of 8-16 weeks for wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), and 8-12 weeks for diabetic retinopathy (DR), following 3 initial monthly doses.
- No safety or efficacy concerns identified with current approved indications
- Maintains existing approved dosing regimens across all indications
- FDA rejected proposal for extended dosing intervals beyond 16 weeks
- Potential limitation on product differentiation and market competitiveness
Verizon Communications (VZ) has announced it will release its first-quarter 2025 earnings on Tuesday, April 22, 2025. The company will host a webcast presentation at 8:30 a.m. Eastern Time, with earnings materials available at 7:00 a.m. ET on Verizon's Investor Relations website.
The materials will include detailed first-quarter results, management commentary with recording and transcript, earnings news release, and financial tables. The company reported revenues of $134.8 billion in 2024.
- Generated substantial revenue of $134.8 billion in 2024
- None.
Medtronic (NYSE: MDT) has received FDA approval for its Simplera Sync™ sensor for use with the MiniMed™ 780G system. The new disposable, all-in-one sensor requires no fingersticks with SmartGuard™ and features a simplified two-step insertion process.
The MiniMed™ 780G system's adaptive algorithm automatically adjusts glucose levels every 5 minutes using Meal Detection™ technology. Real-world data shows users achieve time in range above 70% when using optimal settings. The system works with the world's only 7-day infusion set, reducing injections by 96% compared to daily injections.
A launch of the Simplera Sync™ sensor in the U.S. is scheduled for fall 2025. Currently, the MiniMed™ 780G system operates with the Guardian™ 4 sensor.
- FDA approval expands CGM portfolio with new sensor option
- System achieves >70% time in range in real-world data
- 96% reduction in injections with 7-day infusion set
- Automatic glucose correction every 5 minutes
- Simplified two-step insertion process with no fingersticks required
- launch indicates restricted initial availability
- Launch delayed until fall 2025
PayPal (NASDAQ: PYPL) has launched a new advertising campaign featuring comedian Will Ferrell, following up on their 2024 collaboration. The new ad, set to debut during basketball playoffs, features Ferrell performing a remake of a Fleetwood Mac song while showcasing PayPal's various payment options.
The campaign highlights PayPal's flexible checkout options, including debit card, credit card, bank account, PayPal balance, and Buy Now Pay Later services. Recent product enhancements include biometric logins, faster page load times, and pre-qualified spending amounts for Pay in 4 purchases. The PayPal Debit Mastercard offers 5% cash back on up to $1,000 spent in selected categories monthly, including a new Rideshare and Public Transit category.
The marketing initiative extends beyond television to include out-of-home advertising, digital platforms, streaming, radio, podcasts, influencer partnerships, and social media campaigns.
- Enhanced payment flexibility with multiple checkout options
- Implementation of new technology features (biometric logins, faster loading)
- 5% cashback program on PayPal Debit Mastercard
- Expanded marketing reach across multiple platforms
- Pay in 4 service subject to approval and state-specific eligibility restrictions
GE HealthCare (GEHC) has scheduled the release of its first quarter 2025 financial results for Wednesday, April 30, 2025, before market opening. The company's management team will host a conference call and webcast at 8:30 AM Eastern Time / 7:30 AM Central Time on the same day.
The earnings release, accompanying financial materials, and webcast replay will be accessible through the company's Investor Relations website at investor.gehealthcare.com.
- None.
- None.
Tilray Brands (TLRY) has announced a special stockholders meeting on June 10, 2025, to vote on implementing a reverse stock split at a ratio between 1-to-10 and 1-to-20. The exact ratio will be determined by the Board of Directors.
CEO Irwin D. Simon states this move will align TLRY's outstanding shares with similarly sized companies, ensure Nasdaq listing compliance, and reduce costs by over $1 million annually. The company reports strong financials with debt reduction of $76 million in fiscal 2025, net debt to trailing twelve-months Adjusted EBITDA below 1.0x, and cash/marketable securities exceeding $248 million as of February 28, 2025.
- Significant debt reduction of $76 million in fiscal 2025
- Strong cash position of over $248 million
- Net debt to trailing twelve-months Adjusted EBITDA below 1.0x
- Expected annual cost savings of over $1 million from reverse split
- Need for reverse stock split suggests share price weakness
- Potential compliance issues with Nasdaq listing requirements
- Risk of share value volatility during reverse split implementation
Solventum (NYSE: SOLV) has announced it will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, following the close of U.S. financial markets. The company will host a webcast at 3:30 p.m. CST / 4:30 p.m. EST to discuss the quarterly results and business updates.
The earnings webcast will be accessible through the company's investor relations website at investors.solventum.com. Participants can join via U.S. dial-in at +1 (800) 715-9871 or international dial-in at +1 (646) 307-1963 using Conference ID 6342275. Following the event, the webcast replay, earnings release, presentation slides, and supplemental financial information will be made available on Solventum's investor relations website.
- None.
- None.
Tejon Ranch Co. (NYSE:TRC) is urging shareholders to vote 'FOR' the Company's 10 director nominees on the WHITE proxy card at the upcoming Annual Meeting on May 13, 2025, while opposing Bulldog Investors' nominees. The company emphasizes its successful track record in real estate development and land use entitlements in California.
The company highlights its Tejon Ranch Commerce Center (TRCC) success, which has generated over $110 million in cumulative cash flow from commercial and industrial development. Tejon has reduced discretionary land use entitlement spending by 38% over five years and decreased headcount by nearly half over the past decade while maintaining low debt.
The company argues that Bulldog's nominees lack experience in real estate, land development, and California-specific regulation, warning that their short-term focus could jeopardize long-term value creation and decades of progress in master-planned communities (MPCs) including Mountain Village, Grapevine, and Centennial.
- Generated over $110 million cumulative cash flow from TRCC development
- Reduced discretionary land use entitlement spending by 38% over 5 years
- Decreased headcount by nearly 50% over 10 years improving efficiency
- Maintains low debt levels on balance sheet
- Successfully secured and defended land use approvals for multiple MPCs
- Facing hostile proxy contest from Bulldog Investors
- Requires ongoing capital investment in development projects
- Operating in challenging California regulatory environment